Results 171 to 177 of about 8,866 (177)
Some of the next articles are maybe not open access.
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Nature Reviews Cancer, 2019Jonathan J Havel +2 more
exaly
Biochemistry of Peroxynitrite and Protein Tyrosine Nitration
Chemical Reviews, 2018Gerardo Ferrer-Sueta +2 more
exaly
Appraising iniparib, the PARP inhibitor that never was—what must we learn?
Nature Reviews Clinical Oncology, 2013Joaquin Mateo +2 more
exaly
Acquired resistance to TKIs in solid tumours: learning from lung cancer
Nature Reviews Clinical Oncology, 2014William Pao, Lecia V Sequist
exaly
The evolving landscape of tissue‐agnostic therapies in precision oncology
Ca-A Cancer Journal for CliniciansVivek Subbiah +2 more
exaly
Protein tyrosine phosphatases: from genes, to function, to disease
Nature Reviews Molecular Cell Biology, 2006exaly
SWITCH TO AROMATASE INHIBITOR BETTER THAN CONTINUING TAMOXIFEN
Ca-A Cancer Journal for Clinicians, 2005exaly